The Efficacy of Risdiplam in 7 Patients Previously Treated With Nusinersen for Spinal Muscular Atrophy
The disease-modifying therapies (DMTs) for spinal muscular atrophy (SMA) produced impressive improvements in motor function and survival in clinical trials. However, there are limited real-world data regarding combination or sequential treatment with DMTs. We report the clinical outcomes of risdiplam in 7 SMA patients...